An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
The authors have previously designed, developed, and characterized a novel microencapsulated formulation as a platform for the targeted delivery of therapeutics in an animal model of type 2 diabetes, using the drug probucol (PB). The aim of this study was to optimize PB microcapsules by incorporatin...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Dove Medical Press Ltd.
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/31430 |